WiSEED is a regulated venture capital fund specializing in early-stage biotech and health tech investments. They offer custom financing solutions, including equity and debt, for project developers and small to medium businesses. With over 15 years of experience, they serve both individual and professional investors. Authorized by the French Financial Markets Authority and the Prudential Supervision and Resolution Authority, WiSEED is recognized for its crowdfunding and investment services. Notable investments include Antabio.
